WALTHAM, Mass.--(BUSINESS WIRE)--Based on its recent analysis of the pharmaceutical and biotechnology markets, Frost & Sullivan recognized Phase Forward (NASDAQ: PFWD) with a 2009 Global Product Line Strategy Award. The company accepted the award at the Medical Technologies & Life Sciences Awards banquet Wednesday evening, March 18, at the Hyatt Fisherman’s Wharf in San Francisco, Calif.
